Sfoglia per Autore
Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection
2018-01-01 Carlier, J.; Diao, X.; Huestis, M. A.
Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry
2018-01-01 Diao, X.; Carlier, J.; Zhu, M.; Huestis, M. A.
Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats
2018-01-01 Carlier, J.; Wohlfarth, A.; Salmeron, B. D.; Scheidweiler, K. B.; Huestis, M. A.; Baumann, M. H.
Use of cognitive enhancers: Methylphenidate and analogs
2019-01-01 Carlier, J.; Giorgetti, R.; Varì, M. R.; Pirani, Filippo; Ricci, G.; Busardò, F. P.
Drug-facilitated sexual assaults (DFSA): A serious underestimated issue
2019-01-01 Busardo, F. P.; Vari, M. R.; Trana, A. D. I.; Malaca, S.; Carlier, J.; Di Luca, N. M.
Cannabidiol adverse effects and toxicity
2019-01-01 Huestis, M. A.; Solimini, R.; Pichini, S.; Pacifici, R.; Carlier, J.; Busardo, F. P.
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair
2019-01-01 Busardò, F. P.; Carlier, J.; Giorgetti, R.; Tagliabracci, A.; Pacifici, R.; Gottardi, M.; Pichini, S.
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids
2020-01-01 Carlier, J.; La Maida, N.; Di Trana, A.; Huestis, M. A.; Pichini, S.; Busardo, F. P.
Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects
2020-01-01 Brunetti, P.; Lo Faro, A. F.; Tini, A.; Busardo, F. P.; Carlier, J.
Monitoring Prenatal Exposure to Buprenorphine and Methadone
2020-01-01 Di Trana, A.; La Maida, N.; Tittarelli, R.; Huestis, M. A.; Pichini, S.; Busardo, F. P.; Carlier, J.
Measurement uncertainty in forensic toxicology
2020-01-01 Malaca, S.; Carlier, J.; Pichini, S.; Busardo, F. P.
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
2020-01-01 Di Trana, A.; Carlier, J.; Berretta, P.; Zaami, S.; Ricci, G.
Advances in forensic toxicology
2020-01-01 Malaca, S.; Carlier, J.; Busardo, F. P.
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids
2020-01-01 Carlier, J.; Huestis, M. A.; Zaami, S.; Pichini, S.; Busardo, F. P.
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs
2021-01-01 Brunetti, P.; Pirani, F.; Carlier, J.; Giorgetti, R.; Busardo, F. P.; Lo Faro, A. F.
Pyrrolidinyl synthetic cathinones α-php and 4f-α-pvp metabolite profiling using human hepatocyte incubations
2021-01-01 Carlier, J.; Diao, X.; Giorgetti, R.; Busardo, F. P.; Huestis, M. A.
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites
2021-01-01 Di Trana, A.; Brunetti, P.; Giorgetti, R.; Marinelli, E.; Zaami, S.; Busardo, F. P.; Carlier, J.
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review
2022-01-01 Montanari, E.; Madeo, G.; Pichini, S.; Busardo, F. P.; Carlier, J.
In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping
2022-01-01 Busardo, F. P.; Lo Faro, A. F.; Sirignano, A.; Giorgetti, R.; Carlier, J.
Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives
2022-01-01 Lo Faro, A. F.; Tini, A.; Bambagiotti, G.; Pirani, F.; Faragalli, A.; Carle, F.; Pacella, E.; Ceka, A.; Moretti, M.; Gottardi, M.; Lassandro, N. V.; Nicolai, M.; Lupidi, M.; Mariotti, C.; Busardo, F. P.; Carlier, J.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile